PATENT CLAIM ANALYSIS

Application Number: 15935692
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "422000"]

Abstract:
The present disclosure is directed to injectable formulations that include biodegradable polymers based on trimethylene carbonate (TMC) with mole fractions of polylactic acid (PLA) and/or polyglycolic acid (PGA) that are used to deliver a bioactive agent to a targeted site. Excipients such as polyethylene glycol (PEG) may be added to the formulations to reduce the injection force and/or to modulate the release of the bioactive agent. Suitable biodegradable polymers for use in the injectable formulations include D,L-PLA:TMC, D-PLA:TMC, L-PLA:TMC, TMC:PLA:PGA and variations thereof. Additionally, copolymers of TMC and PLA and terpolymers of TMC:PLA:PGA may be formed into nanoparticles and delivered to the target site with an injectable crosslinkable polyethylene glycol system. In at least one embodiment, the injectable formulations are used to treat ocular diseases.

Claim (Index 15):
The formulation of  claim 13 , wherein said copolymer comprises from 60 to 90 wt. % PLA and from 10 to 40 wt. % TMC.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.89286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14891574', '14124631', '14029211', '12758541', '15582685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7276631680330081
- 35 USC 102 Novelty (BERT): 0.505983284366982
- Combined Prediction Score: 0.7054951796664055
- Mean Citation Score: 194.20186
- Max Citation Score: 218.9938
- Similarity Product: 134.35928788021806

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test